Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for William J Federici. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at William J Federici har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ZYNE / Zynerba Pharmaceuticals Inc Director 0
US:WST / West Pharmaceutical Services, Inc. Sr. VP & CFO 0
Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af William J Federici. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af William J Federici som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-10-11 2023-10-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
U - Other -47.824 0 -100,00
2023-10-11 2023-10-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
U - Other -27.954 47.824 -36,89
2023-06-15 2023-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
S - Sale -115 75.778 -0,15 0,35 -40 26.378
2023-06-15 2023-06-13 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 47.824 75.893 170,38
2022-06-16 2022-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
S - Sale -40 28.069 -0,14 1,01 -40 28.350
2022-06-16 2022-06-14 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 23.109 28.109 462,18
2021-08-05 2021-08-03 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2021-08-05 2021-08-03 4 ZYNE Zynerba Pharmaceuticals, Inc.
Common Stock
A - Award 5.000 5.000
2020-06-11 2020-06-10 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2019-06-13 2019-06-11 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2018-10-02 2018-10-01 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 1.334 1.334 5,16 6.878 6.878
2018-07-03 2018-07-02 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 1.103 1.103 6,24 6.877 6.877
2018-06-11 2018-06-08 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to Buy)
M - Exercise -75.662 0 -100,00
2018-06-11 2018-06-08 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -42.869 227.812 -15,84 96,09 -4.119.282 21.890.487
2018-06-11 2018-06-08 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 75.662 270.681 38,80 21,34 1.614.627 5.776.340
2018-06-07 2018-06-06 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2018-05-11 2018-05-09 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to Buy)
M - Exercise -52.000 0 -100,00
2018-05-11 2018-05-09 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -52.000 195.019 -21,05 87,14 -4.531.280 16.993.985
2018-05-11 2018-05-09 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 52.000 247.019 26,66 16,04 834.340 3.963.425
2018-04-03 2018-04-02 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 1.344 1.344 5,11 6.874 6.874
2018-02-22 2018-02-20 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy)
A - Award 17.544 17.544 89,64 1.572.644 1.572.644
2018-02-15 2018-02-13 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 4.526 195.019 2,38 93,00 420.918 18.136.798
2018-02-14 2017-11-09 5 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -3.400 187.093 -1,78
2018-01-04 2018-01-02 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 754 754 8,29 6.250 6.250
2017-12-12 2017-12-08 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -21.000 190.493 -9,93 99,01 -2.079.210 18.860.745
2017-10-03 2017-10-02 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 1.714 1.714 5,47 9.376 9.376
2017-07-06 2017-07-03 4 PHH Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 882 882 10,63 9.376 9.376
2017-06-09 2017-06-07 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2017-05-18 2017-05-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to Buy)
M - Exercise -54.996 0 -100,00 20,85 -1.146.667
2017-05-18 2017-05-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -2.600 211.493 -1,21 96,00 -249.612 20.304.333
2017-05-18 2017-05-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -52.396 214.093 -19,66 95,42 -4.999.485 20.428.208
2017-05-18 2017-05-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 54.996 266.489 26,00 20,85 1.146.667 5.556.303
2017-04-04 2017-04-03 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 734 734 12,77 9.373 9.373
2017-02-22 2017-02-21 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Options (Right to buy)
A - Award 19.512 19.512 83,47 1.628.667 1.628.667
2017-02-16 2017-02-14 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 4.623 211.202 2,24 86,93 401.877 18.359.801
2016-12-15 2016-12-13 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -2.400 206.295 -1,15
2016-12-15 2016-12-13 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -600 208.695 -0,29
2016-07-20 2016-05-25 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2016-03-02 2016-03-01 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -3.205 208.313 -1,52
2016-02-25 2016-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 30.356 30.356 59,64 1.810.432 1.810.432
2016-02-25 2016-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 9.137 211.518 4,51 59,64 544.931 12.614.942
2015-08-19 2015-08-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -52.678 0 -100,00 22,48 -1.184.465
2015-08-19 2015-08-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -52.678 203.682 -20,55 59,72 -3.146.125 12.164.624
2015-08-19 2015-08-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 52.678 256.360 25,86 22,48 1.184.465 5.764.247
2015-08-06 2015-08-04 4 ZYNE Zynerba Pharmaceuticals, Inc.
Stock Option
A - Award 35.000 35.000
2015-02-26 2015-02-24 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -9.420 203.439 -4,43
2015-02-25 2015-02-23 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 34.348 34.348 54,14 1.859.601 1.859.601
2015-02-23 2015-02-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 12.379 16.274 317,79 51,53 637.890 838.616
2015-02-23 2015-02-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 9.525 212.859 4,68 51,53 490.823 10.968.607
2015-02-13 2014-12-09 4/A WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift 0 203.026 0,00
2014-12-11 2014-12-09 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -2.000 201.026 -0,99
2014-11-24 2014-11-21 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -3.000 203.026 -1,46 51,22 -153.653 10.398.507
2014-08-19 2014-08-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -38.366 0 -100,00 16,29 -625.078
2014-08-19 2014-08-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -38.366 205.460 -15,73 42,56 -1.632.815 8.744.170
2014-08-19 2014-08-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 38.366 243.826 18,67 16,29 625.078 3.972.542
2014-08-14 2014-08-13 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -1.300 205.460 -0,63
2014-02-26 2014-02-24 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 33.751 33.751 47,34 1.597.772 1.597.772
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -3.538 0 -100,00 3,53 -12.489
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -4.795 0 -100,00 4,39 -21.050
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -3.063 0 -100,00 3,74 -11.456
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -13.500 0 -100,00 3,81 -51.435
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -2.157 0 -100,00 3,35 -7.226
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -2.916 0 -100,00 3,42 -9.973
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -2.791 0 -100,00 3,24 -9.043
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -2.436 0 -100,00 2,77 -6.748
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -6.750 0 -100,00 3,43 -23.152
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -2.802 0 -100,00 3,10 -8.686
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -6.750 0 -100,00
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -6.014 0 -100,00
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Stock option (right to buy)
D - Sale to Issuer -7.486 0 -100,00
2014-02-25 2014-02-21 4 PATH NUPATHE INC.
Common Stock
D - Sale to Issuer -13.500 0 -100,00 6,80 -91.800
2014-02-20 2014-02-18 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 12.293 205.615 6,36 48,69 598.546 10.011.386
2014-01-21 2014-01-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
F - Taxes -1.796 192.827 -0,92 49,69 -89.243 9.581.552
2014-01-03 2013-12-31 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 3.538 3.538
2013-11-25 2013-11-22 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -36.000 0 -100,00 12,76 -459.540
2013-11-25 2013-11-22 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
S - Sale -36.000 188.447 -16,04 48,34 -1.740.283 9.109.733
2013-11-25 2013-11-22 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 36.000 224.447 19,10 12,76 459.540 2.865.060
2013-10-02 2013-09-30 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 4.795 4.795
2013-09-03 2013-08-30 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -3.000 93.900 -3,10
2013-07-02 2013-06-30 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 3.063 3.063
2013-06-07 2013-06-05 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 13.500 13.500
2013-04-29 2013-04-24 4 PATH NUPATHE INC.
Common Stock
A - Award 13.500 13.500
2013-04-02 2013-03-31 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 2.157 2.157 2,90 6.248 6.248
2013-03-27 2013-03-26 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 2.018 2.018
2013-02-21 2013-02-19 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 28.534 28.534
2013-02-21 2013-02-19 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 6.522 96.110 7,28 59,11 385.515 5.681.047
2013-01-16 2013-01-14 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
F - Taxes -628 89.155 -0,70 55,05 -34.571 4.907.989
2013-01-03 2012-12-31 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 2.916 2.916 2,29 6.686 6.686
2012-12-18 2012-12-17 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
G - Gift -5.000 87.624 -5,40
2012-12-12 2012-12-10 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
M - Exercise -24.600 0 -100,00 19,37 -476.502
2012-12-12 2012-12-10 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
F - Taxes -14.397 92.624 -13,45 54,96 -791.259 5.090.621
2012-12-12 2012-12-10 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
M - Exercise 24.600 107.021 29,85 19,36 476.379 2.072.464
2012-10-01 2012-09-30 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 2.791 2.791 2,40 6.686 6.686
2012-07-03 2012-06-30 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 2.436 2.436 2,74 6.687 6.687
2012-06-19 2012-01-16 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
F - Taxes -598 79.024 -0,75 38,95 -23.292 3.077.978
2012-06-15 2012-02-21 4/A WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 2.249 79.708 2,90 42,44 95.448 3.382.817
2012-06-11 2012-06-07 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 6.750 6.750
2012-04-03 2012-03-31 4 PATH NUPATHE INC.
Stock Option (Right to Buy)
A - Award 2.802 2.802 2,39 6.686 6.686
2012-02-27 2012-02-24 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
F - Taxes -112 80.481 -0,14 42,48 -4.758 3.418.843
2012-02-23 2012-02-21 4 WST WEST PHARMACEUTICAL SERVICES INC
Stock Option (Right to Buy)
A - Award 40.984 40.984
2012-02-23 2012-02-21 4 WST WEST PHARMACEUTICAL SERVICES INC
Common Stock
A - Award 3.134 80.593 4,05 42,44 133.007 3.420.377
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)